The relationship between blood pressure and cognitive function

Nature Reviews Cardiology

Volumn 7, Issue 12, 2010, Pages 686-698

  Novak, Vera ^a   Hajjar, Ihab ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOSARTAN; NITRENDIPINE; PERINDOPRIL; RESERPINE;

BLOOD PRESSURE REGULATION; BRAIN PERFUSION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOTENSION; MICROANGIOPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 78649444829     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.161     Document Type: Review

References (118)

1. Pereira, M., Lunet, N., Azevedo, A. & Barros, H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J. Hypertens. 27, 963-975 (2009).
2. Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223 (2005).
3. Rutan, G. H. et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 19, 508-519 (1992).
4. Qiu, C., Winblad, B. & Fratiglioni, L. Low diastolic pressure and risk of dementia in very old people: a longitudinal study. Dement. Geriatr. Cogn. Disord. 28, 213-219 (2009).
5. Qiu, C, Winblad, B. & Fratiglioni, L. The agedependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4, 487-499 (2005).
6. Moretti, R. et al. Risk factors for vascular dementia: hypotension as a key point. Vasc. Health Risk Manag. 4, 395-402 (2008).
7. Rose, K. M. et al. Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study. Neuroepidemiology 34, 1-7 (2010).
8. Girouard, H. & Ladecola, C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol. 100, 328-335 (2006).
9. Kadoi, Y. et al. Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia. Stroke 34, 2399-2403 (2003).
10. Katsura, K., Rodriguez de Turco, E. B., Siesjo, B. K. & Bazan, N. G. Effects of hyperglycemia and hypercapnia on lipid metabolism during complete brain ischemia. Brain Res. 1030, 133-140 (2004).
11. Staessen, J. A., Richart, T. & Birkenhager, W. H. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 49, 389-400 (2007).
12. Winblad, B. et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256, 240-246 (2004).
13. Cherbuin, N. et al. Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement. Geriatr. Cogn. Disord. 28, 47-55 (2009).
14. Nagai, M., Hoshide, S. & Kario, K. Hypertension and dementia. Am. J. Hypertens. 23, 116-124 (2010).
15. Panerai, R. B. Assessment of cerebral pressure autoregulation in humans-a review of measurement methods. Physiol. Meas. 19, 305-338 (1998).
16. Aaslid, R., Lindegaard, K. E, Sorteberg, W. & Nornes, H. Cerebral autoregulation dynamics in humans. Stroke 20, 45-52 (1989).
17. Lipsitz, L. A., Mukai, S., Hammer, J., Gagnon, M. & Babikian, V. L. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke 31, 1897-1903 (2000).
18. Novak, V., Novak, P., Spies, J. M. & Low, P. A. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 29, 104-111 (1998).
19. Hu, K. et al. Altered phase interactions between spontaneous blood pressure and flow fluctuations in type 2 diabetes mellitus: nonlinear assessment of autoregulation. Physica A 387, 2279-2292 (2008).
20. Eames, P. J., Blake, M. J., Dawson, S. L., Panerai, R. B. & Potter, J. F. Dynamic cerebral autoregulation and beat-to-beat blood pressure control are impaired in acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 72, 467-473 (2002).
21. Novak, V. et al. Multimodal pressure-flow method to assess dynamics of cerebral autoregulation in stroke and hypertension. Biomed. Eng. Online 3, 39 (2004).
22. Novak, V. et al. Altered cerebral vasoregulation in hypertension and stroke. Neurology 60, 1657-1663 (2003).
23. [No authors listed] Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46, 1470 (1996).
24. Horowitz, D. R. & Kaufmann, H. Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure. Clin. Auton. Res. 11, 363-367 (2001).
25. Novak, V. et al. Cerebral flow velocities during daily activities depend on blood pressure in patients with chronic ischemic infarctions. Stroke 41, 61-66 (2010).
26. van Lieshout, J. J. & Wieling, W. Perfusion of the human brain: a matter of interactions. J. Physiol. 551, 402 (2003).
27. Davidson, E., Rotenbeg, Z., Fuchs, J., Weinberger, I. & Agmon, J. Transient ischemic attack-related syncope. Clin. Cardiol. 14, 141-144 (1991).
28. Zhang, R., Zuckerman, J. H., Giller, C. A. & Levine, B. D. Transfer function analysis of dynamic cerebral autoregulation in humans. Am. J. Physiol. 274, H233-H241 (1998).
29. Tiecks, F. P. et al. Effects of the Valsalva maneuver on cerebral circulation in healthy adults. A transcranial Doppler Study. Stroke 26, 1386-1392 (1995).
30. Lundberg, N. Continuous recording and control of verntricular fluid pressure in neurosurgical practice. Acta Psychiatr. Scand. 36, 1-193 (1960).
31. Maeda, M., Takahashi, K., Miyazaki, M. & Ishii, S. The role of the central monoamine system and the cholinoceptive pontine area on the oscillation of ICP "pressure waves". In Intracranial Pressure VI (eds Miller, J. D., Teasdale, G. M., Rowan, J. O., Galbraith, S. L. & Mendelow, A. D.) 151-155 (Springer-Verlag, Berlin, 1986).
32. Steinmeier, R. et al. Slow rhythmic oscillations in blood pressure, intracranial pressure, microcirculation, and cerebral oxygenation. Stroke 27, 2236-2243 (1996).
33. Panerai, R. B., Eames, P. J. & Potter, J. F. Multiple coherence of cerebral blood flow velocity in humans. Am. J. Physiol. Heart Circ. Physiol. 291, H251-H259 (2006).
34. Latka, M. et al. Phase dynamics in cerebral autoregulation. Am. J. Physiol. Heart Circ. Physiol. 289, H2272-H2279 (2005).
35. Hu, K., Peng, C. K., Czosnyka, M., Zhao, P & Novak, V. Nonlinear assessment of cerebral autoregulation from spontaneous blood pressure and cerebral blood flow fluctuations. Cardiovasc. Eng. 8, 60-71 (2008).
36. Blaber, A. P et al. Transfer function analysis of cerebral autoregulation dynamics in autonomic failure patients. Stroke 28, 1686-1692 (1997).
37. Schondorf, R., Stein, R., Roberts, R., Benoit, J. & Cupples, W. A. Dynamic cerebral autoregulation is preserved in neurally mediated syncope. J. Appl. Physiol. 91, 2493-2502 (2001).
38. 2 responsiveness as an indicator of collateral reserve capacity in patients with carotid artery disease. Br. J. Surg. 72, 348-351 (1985).
39. Brown, G. G., Clark, C. & Liu, T. T. Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications. J. Int. Neuropsychol. Soc. 13, 526-538 (2007).
40. Chimowitz, M. I. et al. Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction. Neurology 43, 353-357 (1993).
41. Last, D. et al. Global and regional effects of type 2 diabetes mellitus on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30, 1193-1199 (2007).
42. Zhao, P et al. Vasoreactivity and peri-infarct hyperintensities in stroke. Neurology 72, 643-649 (2009).
43. Waldstein, S. R., Giggey, P. P., Thayer, J. F. & Zonderman, A. B. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 45, 374-379 (2005).
44. Waldstein, S. R. et al. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 51, 99-104 (2008).
45. Ikram, M. K. et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain 129, 182-188 (2006).
46. Vermeer, S. E. et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 27, 1215-1222 (2003).
47. deGroot, J. C. et al. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 56, 1539-1541 (2001).
48. Manschot, S. M. et al. for the Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106-1113 (2006).
49. Meyer, J. S. Regulation of cerebral hemodynamics in health and disease. Eur. Neurol. 22 (Suppl. 1), 47-60 (1983).
50. Dandona, P, James, I. M., Newbury, P. A., Woollard, M. L. & Beckett, A. G. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br. Med. J. 29, 325-326 (1978).
51. Appelman, A. P et al. White matter lesions and brain atrophy: more than shared risk factors? A systematic review. Cerebrovasc. Dis. 28, 227-242 (2009).
52. deGroot, J. C., de Leeuw, F. E. & Breteler, M. M. Cognitive correlates of cerebral white matter changes. J. Neural Transm. Suppl. 53, 41-67 (1998).
53. Novak, V., Abduljalil, A. M., Novak, P & Robitaille, R. M. High resolution ultra high field MRI of stroke. Magn. Reson. Imaging 23, 539-548 (2005).
54. Kario, K. et al. Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45, 887-983 (2005).
55. Marstrand, J. R. et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 34, 972-976 (2002).
56. DeCarli, C. et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45, 2077-2084 (1995).
57. Mehagnoul-Schipper, D. J., Colier, W. N. & Jansen, R. W. Reproducibility of orthostatic changes in cerebral oxygenation in healthy subjects aged 70 years and older. Clin. Physiol. 21, 77-84 (2001).
58. Novak, V et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 29, 1529-1534 (2006).
59. Enzinger, C., Fazekas, F., Ropele, S. & Schmidt, R. Progression of cerebral white matter lesions-clinical and radiological considerations. J. Neurol. Sci. 257, 5-10 (2007).
60. van Raamt, R. F. et al. for the SMART Study Group. Arterial blood flow to the brain in patients with vascular disease: the SMART Study. Radiology 240, 515-521 (2006).
61. Xu, W. L., Qiu, C. X., Wahlin, A., Winblad, B. & Fratiglioni, L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63, 1181-1186 (2004).
62. Vermeer, S. E. et al. for the Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 34, 1126-1129 (2003).
63. Jokinen, H. et al. for the LADIS Group. MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc. Dis. 27, 336-344 (2009).
64. Sachdev, P. S., Chen, X., Joscelyne, A., Wen, W. & Brodaty, H. Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: the Sydney Stroke Study. Am. J. Geriatr. Psychiatry 15, 487-496 (2007).
65. Guo, X. et al. Blood pressure components and changes in relation to white matter lesions: a 32-year prospective population study. Hypertension 54, 57-62 (2009).
66. Launer, L. J. et al. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension 55, 1352-1359 (2010).
67. Wolf, P. A. et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr. Alzheimer Res. 4, 111-116 (2007).
68. Selim, M., Jones, R., Novak, P., Zhao, P & Novak, V. The effects of body mass index on cerebral blood flow velocity. Clin. Auton. Res. 18, 331-338 (2008).
69. Knopman, D. S. et al. for the Atherosclerosis Risk in Communities Study. Brain MRI Study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 5, 207-214 (2009).
70. Pavlik, V. N., Hyman, D. J. & Doody, R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 24, 42-50 (2005).
71. Wadley, V. G. et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke 38, 1143-1147 (2007).
72. Tsivgoulis, G. et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology 73, 589-595 (2009).
73. Singh-Manoux, A. & Marmot, M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J. Clin. Epidemiol. 58, 1308-1315 (2005).
74. Kitagawa, K. et al. Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease. Hypertens. Res. 32, 816-820 (2009).
75. Peters, R. et al. Vascular risk factors and cognitive function among 3, 763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis. Int. Psychogeriatr. 21, 359-368 (2009).
76. Peters, R. et al. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG): an ongoing randomised, doubleblind, placebo-controlled trial. Drugs Aging 23, 83-92 (2006).
77. Peters, R. et al. for the HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 7, 683-689 (2008).
78. Peters, R. et al. Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET. Age Ageing 38, 521-527 (2009).
79. Korf, E. S., White, L. R., Scheltens, P & Launer, L. J. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 29, 2268-2274 (2006).
80. Vinyoles, E., De La Figuera, M. & Gonzalez-Segura, D. Cognitive function and blood pressure control in hypertensive patients over 60 years of age: COGNIPRES study. Curr. Med. Res. Opin. 24, 3331-3339 (2008).
81. Reitz, C., Tang, M. X., Manly, J., Mayeux, R. & Luchsinger, J. A. Hypertension and the risk of mild cognitive impairment. Arch. Neurol. 64, 1734-1740 (2007). (Pubitemid 350254935)
82. Hussain, M., Ooi, W. L. & Lipsitz, L. A. Intraindividual postural blood pressure variability and stroke in elderly nursing home residents. J. Clin. Epidemiol. 54, 488-494 (2001).
83. Rose, K. M. et al. Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study. J. Hum. Hypertens. 16, 771-777 (2002).
84. Rose, K. M. et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 114, 630-636 (2006).
85. Yap, P. L., Niti, M., Yap, K. B. & Ng, T. P Orthostatic hypotension, hypotension and cognitive status: early comorbid markers of primary dementia? Dement Geriatr. Cogn Disord. 26, 239-246 (2008).
86. Fedorowski, A. et al. Consequences of orthostatic blood pressure variability in middleaged men (The Malmo Preventive Project). J. Hypertens. 28, 551-559 (2010).
87. Kähönen-Väre, M. et al. Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. Aging Clin. Exp. Res. 16, 147-152 (2004).
88. Waldstein, S. R., Brown, J. R., Maier, K. J. & Katzel, L. I. Diagnosis of hypertension and high blood pressure levels negatively affect cognitive function in older adults. Ann. Behav. Med. 29, 174-180 (2005).
89. Stewart, R. et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 54, 233-240 (2009).
90. Razay, G., Williams, J., King, E., Smith, A. D. & Wilcock, G. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study. Dement. Geriatr. Cogn. Disord. 28, 70-74 (2009).
91. Gorospe, E. C. & Dave, J. K. The risk of dementia with increased body mass index. Age Ageing 36, 23-29 (2007).
92. Applegate, W. B. et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch. Intern. Med. 154, 2154-2160 (1994).
93. Prince, M. J., Bird, A. S., Blizard, R. A. & Mann, A. H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 312, 801-815 (1996).
94. Forette, F et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351 (1998).
95. Hanon, O., Seux, M. L., Lenoir, H., Rigaud, A. S. & Forette, F. Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr. Hypertens. Rep. 6, 201-207 (2004).
96. Tzourio, C. et al. for the PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163, 1069-1075 (2003).
97. Arima, H. et al. for the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. J. Hypertens. 28, 395-400 (2010).
98. Bosch, J. et al. for the HOPE Investigators. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 324, 699-702 (2002).
99. Bosch, J. et al. for the HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 112, 1339-1346 (2005).
100. Lithell, H. et al. for the SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J. Hypertens. 21, 875-886 (2003). (Pubitemid 36677151)
101. Trenkwalder, P The Study on Cognition and Prognosis in the Elderly (SCOPE)-recent analyses. J. Hypertens. Suppl. 24, S107-S114 (2006).
102. Saxby, B. K., Harrington, F, Wesnes, K. A., McKeith, I. G. & Ford, G. A. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology 70, 1858-1866 (2008).
103. Feigin, V., Ratnasabapathy, Y & Anderson, C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J. Neurol. Sci. 229-230, 151-155 (2005).
104. Diener, H. C. et al. for the PRoFESS Study Group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 7, 875-884 (2008).
105. Sleight, P et al. for the ONTARGET Investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J. Hypertens. 27, 1360-1369 (2009).
106. Pendlebury, S. T, Cuthbertson, F. C., Welch, S. J., Mehta, Z. & Rothwell, P. M. Underestimation of cognitive impairment by mini-mental state examination versus the Montreal cognitive assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41, 1290-1293 (2010).
107. Oveisgharan, S. & Hachinski, V. Hypertension, executive dysfunction, and progression to dementia: the Canadian study of health and aging. Arch. Neurol. 67, 187-192 (2010).
108. Hajjar, I. et al. Association of blood pressure elevation and nocturnal dipping with brain atrophy, perfusion and functional measures in stroke and nonstroke individuals. Am. J. Hypertens. 23, 17-23 (2010).
109. Hajjar, I. et al. A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks. J. Gerontol. A Biol. Sci. Med. Sci. 64, 994-1001 (2009).
110. Bejan-Angoulvant, T. et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J. Hypertens. 28, 1366-1372 (2010).
111. Li, N. C. et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340, b5465 (2010).
112. Fogari, R. et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J. Hum. Hypertens. 17, 781-785 (2003).
113. Fogari, R. et al. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J. Hum. Hypertens. 20, 177-185 (2006).
114. Tedesco, M. A. et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am. J. Hypertens. 12, 1130-1134 (1999).
115. Sink, K. M. et al. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch. Intern. Med. 169, 1195-1202 (2009).
116. Forette, F. et al. for the Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch. Intern. Med. 162, 2046-2052 (2002).
117. Muldoon, M. F., Manuck, S. B., Shapiro, A. P, & Waldstein, S. R. Neurobehavioral effects of antihypertensive medications. J. Hypertens. 6, 549-559 (1991).
118. Fogari, R. et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur. J. Clin. Pharmacol. 59, 863-868 (2004).